Early rheumatoid disease. I. Onset.-Reference-Cited by-同舟云学术

Early rheumatoid disease. I. Onset.

Published:1976-08-01 Issue:4 Volume:35 Page:357-360
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Annals of the Rheumatic Diseases

Author:

Fleming A,Crown J M,Corbett M

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference13 articles.

1. Ann. rheum;ASSOCIATION, A.M.E.R.C.A.N.R.H.E.U.M.A.T.I.S.M.;Dis; 49 (Diagnostic criteria for rheumatoid arthritis: 1958 revision,1959

2. BUCKLEY, C. W. (1936) Lancet, 1, 1023 (Prognosis in arthritis)

3. BYWATERS, E. G. L., AND DRESNER, E. (1952) Quart. J. Med., 21, 463 (The prognosis in rheumatoid arthritis)

4. Ann. rheum;CECIL, R.L.; ARCHER, B.H.;J. Amer. med. Ass; Medical and social aspects of the treatment of rheumatoid arthritis: with special reference to factors affecting prognosis) EGELIUs,1926

5. In 'A Treatise on Rheumatism and Rheumatoid Arthritis';GARROD, A.E.;J; Onset, early stages and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11 year follow-up,1890

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and cellular contributors of Rheumatoid Arthritis;International Journal of Drug Discovery and Pharmacology;2024-08-29

2. Trivalent chromium versus baricitinib for rheumatoid arthritis treatment: first phase 2/3 randomized controlled trial, is trivalent chromium the upcoming immune-modulator?;Inflammopharmacology;2024-07-19

3. The first involved joints and associated factors in patients with rheumatoid arthritis;Archives of Rheumatology;2024-05-05

4. Skin involvement in other autoimmune diseases;The Rose and Mackay Textbook of Autoimmune Diseases;2024

5. Seasonality and Autoimmunity;Infection and Autoimmunity;2024